Home > Financial Ratios > CIPLA

CIPLA
Core EBITDA Growth

    Back to All Ratios
CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results

CIPLA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 27.9013.836.9827.27-0.66

What is the latest Core EBITDA Growth ratio of CIPLA ?

The latest Core EBITDA Growth ratio of CIPLA is 27.90 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202427.90
Mar202313.83
Mar20226.98
Mar202127.27
Mar2020-0.66

How is Core EBITDA Growth of CIPLA Trending?

Years Core EBITDA Growth % Change
Mar2024 27.9
101.74
Mar2023 13.83
98.14
Mar2022 6.98
-74.40
Mar2021 27.27
Positive
Mar2020 -0.66 -

Other Financial Ratios of CIPLA


Compare Core EBITDA Growth ratio of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹118,164.0 Cr 3.4% 0.1% -3.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,900.0 Cr -1.3% 4.7% 3.3% Stock Analytics
DIVIS LABORATORIES ₹148,474.0 Cr 1.9% 1.5% 41.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹105,849.0 Cr -4.8% 1.9% 20.3% Stock Analytics
MANKIND PHARMA ₹97,009.6 Cr -4% 4% -1.9% Stock Analytics
DR REDDYS LABORATORIES ₹92,553.6 Cr -0.1% -1% -11.3% Stock Analytics


CIPLA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

3.4%

0.1%

-3.1%

SENSEX

-1.5%

1.1%

1.2%


You may also like the below Video Courses